LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

UNH

501.64

+1.75%↑

JNJ

147.85

+1.57%↑

MRK

125.78

+0.49%↑

HomeStock ListCara Therapeutics Inc

Cara Therapeutics Inc

Closed

Sector Healthcare

0.7

Overview

Share price change

24h

Current

Min

0.6

Max

0.7

Key metrics

By Trading Economics

Income

3.4M

-28M

Sales

-1.9M

3M

EPS

-0.59

Profit margin

-576.079

Employees

55

EBITDA

3.4M

-29M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+715.79 upside

Dividends

By Dow Jones

Next Earnings

13 May 2024

Market Stats

By TradingEconomics

Market Cap

-1.9M

48M

Previous open

0.7

Previous close

0.7

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

Cara Therapeutics Inc Chart

Related News

16 Apr 2024, 23:25 UTC

Earnings

Rio Tinto Maintains Annual Guidance After 1Q Iron-Ore Shipments Fall 10%

16 Apr 2024, 22:41 UTC

Earnings

America Movil 1Q Net Profit Falls on Higher Financial Costs

16 Apr 2024, 18:36 UTC

Earnings

Trending: UnitedHealth 1Q Beats Expectations Despite Cyberattack

16 Apr 2024, 22:38 UTC

Earnings

Rio Tinto: First Western Range Ore on Track for 2025>RIO.AU

16 Apr 2024, 22:25 UTC

Earnings

UnitedHealth Stock Jumps After Earnings Beat Expectations, Despite Cyberattack -- 3rd Update

16 Apr 2024, 22:24 UTC

Market Talk

Canada Budget Plan To Complicate Bank of Canada Rate Outlook -- Market Talk

16 Apr 2024, 22:16 UTC

Acquisitions, Mergers, Takeovers

Yuexiu Property to Build Residential Properties for Sale in Land Parcel

16 Apr 2024, 22:15 UTC

Acquisitions, Mergers, Takeovers

Yuexiu Property to Pay CNY1.60B for Land Parcel

16 Apr 2024, 22:15 UTC

Acquisitions, Mergers, Takeovers

Yuexiu Property Wins Tender to Buy Land Parcel in Shanghai

16 Apr 2024, 21:46 UTC

Earnings

America Movil 1Q EBITDA MXN80.58B, Down 2.6% on Year >AMX

16 Apr 2024, 21:44 UTC

Earnings

America Movil 1Q Rev MXN203.3B, Down 2.7% on Year >AMX

16 Apr 2024, 21:43 UTC

Earnings

America Movil 1Q Net MXN13.49B, Down 55% on Year >AMX

16 Apr 2024, 20:58 UTC

Market Talk

Mexican Stocks Close Lower; Peso Retreats Against Dollar -- Market Talk

16 Apr 2024, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

16 Apr 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

16 Apr 2024, 20:37 UTC

Top News

Stocks Stabilize, Treasury Yields Reach New Five-Month Highs -- WSJ

16 Apr 2024, 20:24 UTC

Earnings

Investment Banking Bounceback Powers Big U.S. Lenders -- Update

16 Apr 2024, 20:23 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16 Apr 2024, 20:23 UTC

Market Talk

Canada Eyes C$1 Billion a Year in Savings Through Attrition in Public Sector -- Market Talk

16 Apr 2024, 20:17 UTC

Market Talk

Canada Seen Embracing Tax-and-Spend Budget Plan -- Market Talk

16 Apr 2024, 20:15 UTC

Market Talk

Canada Comes Under Scrutiny on Capital-Gains Tax Rise -- Market Talk

16 Apr 2024, 19:59 UTC

Earnings

What's Behind Record Client Assets at Wealth Management Firms? -- Barrons.com

16 Apr 2024, 19:26 UTC

Market Talk

Oil Futures Settle Lower in Quiet Trade -- Market Talk

16 Apr 2024, 19:12 UTC

Market Talk

U.S. Natural Gas Futures Gain in Rebound Off Lows -- Market Talk

16 Apr 2024, 18:51 UTC

Top News

Tesla Delays Cybertruck Deliveries, Leaving Buyers Confused -- 2nd Update

16 Apr 2024, 18:51 UTC

Market Talk

Canada's Mortgage Market Helps Explain Weaker Consumption Than in US -- Market Talk

16 Apr 2024, 18:41 UTC

Market Talk
Earnings

LVMH Facing Gradual Recovery in Travel Retail Business DFS -- Market Talk

16 Apr 2024, 18:38 UTC

Earnings

UnitedHealth Stock Jumps After Earnings Beat Expectations, Despite Cyberattack -- 2nd Update

16 Apr 2024, 18:08 UTC

Earnings

UnitedHealth Stock Is Lifting the Dow Today -- WSJ

16 Apr 2024, 18:05 UTC

Market Talk

Bank of Canada Governor Macklem Notes Cooling Core Inflation Measures -- Market Talk

Peer Comparison

Price change

Cara Therapeutics Inc forecast

Price Target

By TipRanks

715.79% upside

12 Months Forecast

Average 6.2 USD  715.79%

High 10 USD

Low 3.6 USD

Based on 3 Wall Street analysts offering 12 month price targets forCara Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

3 ratings

3

Buy

0

Hold

0

Sell

Technical Score

By Trading Central

N/A / 0.831Support & Resistance

Short Term

Very Strong Bearish Evidence

Intermediate Term

Weak Bullish Evidence

Long Term

No Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

$

About Cara Therapeutics Inc

Cara Therapeutics, Inc. is a clinical-stage biopharmaceutical company that is focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors (KORs). The Company is developing a class of product candidates KORSUVA (CR845/difelikefalin), which is a KOR agonist that targets the body’s peripheral nervous system, as well as certain immune cells. The Company is also conducting preclinical studies and clinical trials of CR845/difelikefalin-based product candidates.